Healthcare

JNJ.N
PFE.N
MRK.N

UPDATE 1-Novo wins EU recommendation for two-in-one diabetes drug

* Xultophy combines long-acting insulin deguldec and Victoza

8:13am EDT

Philips appoints Morgan Stanley for lighting unit sale -sources

FRANKFURT, July 25 - Philips has picked Morgan Stanley to organise the sale of a stake in its lighting components business, which it is carving out as part of a strategic reshuffling, three people familiar with the matter said.

UPDATE 1-WHO seeks humanitarian corridor to evacuate Gaza wounded

GENEVA, July 25 - The World Health Organisation (WHO) called on Friday for a humanitarian corridor to be set up in Gaza to allow aid workers to evacuate the wounded and bring in life-saving medicines.

7:56am EDT

Novo sees two-in-one diabetes drug in Europe in H1 2015

COPENHAGEN, July 25 - Novo Nordisk, the world's largest insulin maker, said on Friday it expected European Commission marketing authorisation for its new two-in-one insulin drug within three months after an EU medicines agency recommended the drug.

7:38am EDT
Healthcare
Johnson & Johnson $102.20 +0.01%
Pfizer Inc $30.39 -0.33%
Merck & Co Inc $58.21 +0.17%

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.